All Wyeth articles
-
Business
Pfizer agrees potential $785m fraud settlement
Whistleblower case relates to claims of Wyeth overcharging for acid reflux drugs between 2001 and 2006
-
BusinessRecord insider trading case hits pharma
US authorities claim that hedge fund manager made illicit gains of $276 million in response to confidential clinical trial data